MELAS症候群は,高縮性心筋症候群と進行性心不全を伴う:多システム診断の課題
Jozef Dodulík1,2, Marie Lazárová1,2, Eva Kapsová1,2
1Department of Internal Medicine and Cardiology, University Hospital Ostrava, 708 00 Ostrava, Czech Republic.
Journal of clinical medicine
|February 13, 2026
まとめ
乳酸酸化と脳卒中のようなエピソード (MELAS) を伴うミトコンドリア脳髄膜病は,心筋病として現れる可能性があります. 早期の遺伝子検査は,このまれな疾患,特に腎臓と聴覚の問題を共存して診断するために非常に重要です.
科学分野:
- 遺伝学 遺伝学とは
- 心臓病学 心臓病学
- 神経学 神経学とは
背景:
- 乳酸酸化と脳卒中のようなエピソード (MELAS) を伴うミトコンドリア脳内膜症は,珍しい遺伝疾患です.
- ハーパトロフィック心筋病症や心不全を含む心臓の関与は,MELASでしばしば認識されていない.
- MT-TL1のm.3243A>G変種は,MELASの最も一般的な原因です.
研究 の 目的:
- 原因不明の心筋疾患においてMELASを考慮する重要性を強調する.
- MELASの診断における遺伝子検査の役割を強調する.
- 心臓発作によるMELASの診断の課題と管理を図解する.
主な方法:
- 43歳の男性,慢性腎臓病と難聴で心不全を呈した症例報告.
- 診断作業には,エコーカルディオグラフィー,心筋MRI,冠動脈血管図,全エクソームシーケンシングが含まれていました.
- 遺伝子検査により,MELAS症候群を確認するm.3243A>G MT-TL1変異が確認されました.
主要な成果:
- 患者は急性不補償性心不全と重度の左心室機能不全を示した.
- 心臓画像検査では,拡散性多発症と線維症を伴う非発血性心筋病気が明らかになりました.
- 全エクソーム配列解析により,m.3243A>G変異によるMELAS症候群が確認されました.
結論:
- 原因不明の心筋病,特に腎臓と聴覚の欠乏症は,MELASのようなミトコンドリア障害の検討を正当化します.
- 多様性評価と遺伝子検査は,正確な診断と管理に不可欠です.
- MELASの早期診断は,適切な心不全治療と心臓移植のような高度な治療を検討することを可能にします.
キーワード:
メラス症候群 (MELAS syndrome) とは,メラス症候群 (MELAS syndrome) とは,メラス症候群 (MELAS syndrome) とは,遺伝子検査 遺伝子検査 遺伝子検査心不全 (HF) とはハイパートロフィック心筋病変 (HCM)ミトコンドリア疾患はミトコンドリアの病気です.さらに関連する動画
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.3K
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
2.0K
関連する概念動画
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
530
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
530
01:30Heart Failure IV: Classification and Diagnostic Evaluation
429
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
429
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
01:17Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
01:27Heart Failure I: Introduction
958
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
958
01:22Heart Failure VI: Adjunct Therapies
399
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
399